Substituted imidazo[4,5-c]quinoline compounds with an N-1 branched group
US11370788B2 · kind B2 · utility
0Cited by
28References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 2019 |
| Grant date | Jun 28, 2022 |
| Priority date | — |
| Expiry date | Aug 31, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Imidazo[4,5-c]quinoline compounds having a substituent that is attached at the N−1 position by a branched group, single enantiomers of the compounds, pharmaceutical compositions containing the compounds, and methods of making the compounds are disclosed. Methods of use of the compounds as immune response modifiers, for inducing cytokine biosynthesis in humans and animals, and in the treatment of diseases including infectious and neoplastic diseases are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.